Prop-2-yn-1-yl-2-((3S,14S,15S,E)-7,14-dimethyl-11-methylene-15-((R)-14-methylpentadecan-2-yl)-2,5,8,13-tetraoxo-1-oxa-4,7,12-triazacyclopentadec-9-en-3-yl)acetate

ID: ALA4167966

Chembl Id: CHEMBL4167966

PubChem CID: 145955719

Max Phase: Preclinical

Molecular Formula: C35H55N3O7

Molecular Weight: 629.84

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C#CCOC(=O)C[C@@H]1NC(=O)CN(C)C(=O)/C=C/C(=C)NC(=O)[C@@H](C)[C@H]([C@H](C)CCCCCCCCCCCC(C)C)OC1=O

Standard InChI:  InChI=1S/C35H55N3O7/c1-8-22-44-32(41)23-29-35(43)45-33(26(4)19-17-15-13-11-9-10-12-14-16-18-25(2)3)28(6)34(42)36-27(5)20-21-31(40)38(7)24-30(39)37-29/h1,20-21,25-26,28-29,33H,5,9-19,22-24H2,2-4,6-7H3,(H,36,42)(H,37,39)/b21-20+/t26-,28+,29+,33+/m1/s1

Standard InChI Key:  FCUPBJHYBSOJHL-QWDZEWPISA-N

Alternative Forms

  1. Parent:

    ALA4167966

    ---

Associated Targets(Human)

PANC-1 (6144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ASPC1 (1310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PaTu 8988t (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 629.84Molecular Weight (Monoisotopic): 629.4040AlogP: 4.83#Rotatable Bonds: 16
Polar Surface Area: 131.11Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.88CX Basic pKa: CX LogP: 5.44CX LogD: 5.44
Aromatic Rings: Heavy Atoms: 45QED Weighted: 0.14Np Likeness Score: 0.75

References

1. Chen J, Li J, Wu L, Geng Y, Yu J, Chong C, Wang M, Gao Y, Bai C, Ding Y, Chen Y, Zhang Q..  (2018)  Syntheses and anti-pancreatic cancer activities of rakicidin A analogues.,  151  [PMID:29656202] [10.1016/j.ejmech.2018.03.078]

Source